Privia Health Group (NASDAQ:PRVA) Research Coverage Started at Macquarie

Macquarie initiated coverage on shares of Privia Health Group (NASDAQ:PRVA) in a research report released on Monday morning, Marketbeat.com reports. The brokerage issued an outperform rating and a $25.00 price objective on the stock.

Several other analysts have also recently commented on PRVA. Robert W. Baird raised their target price on Privia Health Group from $23.00 to $24.00 and gave the company an “outperform” rating in a research report on Monday, August 26th. Truist Financial lifted their price objective on shares of Privia Health Group from $24.00 to $27.00 and gave the company a “buy” rating in a research note on Friday, November 8th. KeyCorp started coverage on shares of Privia Health Group in a research report on Friday, October 11th. They issued an “overweight” rating and a $23.00 target price for the company. Barclays boosted their price target on shares of Privia Health Group from $19.00 to $21.00 and gave the stock an “equal weight” rating in a research report on Friday, November 8th. Finally, JPMorgan Chase & Co. increased their price objective on shares of Privia Health Group from $27.00 to $28.00 and gave the company an “overweight” rating in a report on Friday, November 29th. Two analysts have rated the stock with a hold rating, twelve have given a buy rating and two have issued a strong buy rating to the stock. According to data from MarketBeat, the stock currently has an average rating of “Buy” and a consensus price target of $24.80.

Privia Health Group Trading Down 2.2 %

NASDAQ PRVA opened at $20.34 on Monday. The company has a 50-day moving average price of $20.19 and a two-hundred day moving average price of $19.11. Privia Health Group has a 52 week low of $15.92 and a 52 week high of $24.30. The stock has a market cap of $2.44 billion, a price-to-earnings ratio of 203.42, a price-to-earnings-growth ratio of 5.45 and a beta of 0.83.

Hedge Funds Weigh In On Privia Health Group

A number of hedge funds have recently modified their holdings of PRVA. FMR LLC lifted its holdings in shares of Privia Health Group by 1.5% during the third quarter. FMR LLC now owns 18,169,043 shares of the company’s stock valued at $330,858,000 after purchasing an additional 271,645 shares during the last quarter. Geode Capital Management LLC boosted its holdings in shares of Privia Health Group by 1.0% in the third quarter. Geode Capital Management LLC now owns 2,415,022 shares of the company’s stock worth $43,986,000 after buying an additional 23,178 shares during the period. Franklin Resources Inc. increased its position in shares of Privia Health Group by 2.2% in the third quarter. Franklin Resources Inc. now owns 1,300,240 shares of the company’s stock worth $23,092,000 after acquiring an additional 28,480 shares in the last quarter. Millennium Management LLC raised its holdings in shares of Privia Health Group by 2,994.2% during the second quarter. Millennium Management LLC now owns 1,138,526 shares of the company’s stock valued at $19,788,000 after acquiring an additional 1,101,730 shares during the period. Finally, Dimensional Fund Advisors LP lifted its position in shares of Privia Health Group by 18.4% in the 2nd quarter. Dimensional Fund Advisors LP now owns 1,118,619 shares of the company’s stock valued at $19,441,000 after acquiring an additional 173,934 shares in the last quarter. 94.48% of the stock is currently owned by institutional investors and hedge funds.

About Privia Health Group

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.